[1] |
Both T, Dalm VA, Hagen PM, et al. Reviewing primary Sjögren's syndrome: beyond the dryness-From pathophysiology to diagnosis and treatment[J]. International Journal of Medical Sciences, 2017, 14(3):191-200.
|
[2] |
Liew MS, Zhang M, Kim E, et al. Prevalence and predictors of Sjögren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye[J]. Br J Ophthalmol, 2012, 96(12):1498-1503.
|
[3] |
Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca[J]. Current Eye Research, 1999, 19(3):201-211.
|
[4] |
Bowman SJ, Ibrahim GH, Holmes G, et al. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK[J]. Acta Rheumatologica Scandinavica, 2004, 33(1):39-43.
|
[5] |
Baimpa E, Dahabreh IJ, Voulgarelis M, et al. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects[J]. Medicine, 2009, 88(5):284-293.
|
[6] |
Valim V, Zandonade E, Pereira AM, et al. Primary Sjögren's syndrome prevalence in a major metropolitan area in Brazil[J]. Revista Brasileira De Reumatologia, 2013, 53(1):24-28.
|
[7] |
Fauchais AL, Martel C, Vidal E. Epidemiology and physiopathogy of Sjögren's syndrome[J]. La Revue Du Praticien, 2012, 62(2):218-220.
|
[8] |
Tsuboi H, Asashima H, Takai C, et al. Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan[J]. Modern Rheumatology, 2014, 24(3):464-470.
|
[9] |
Kim HJ, Kim KH, Hann HJ, et al. Incidence, Mortality and Causes of Death in Physician-Diagnosed Primary Sjögren′s Syndrome in Korea-A Nationwide, Population-Based Study[J]. Semin Arthritis Rheum, 2017,47(2):222-227.
|
[10] |
中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志,2010,14(11):766-768.
|
[11] |
袁锁娟,陆雯俊,沈友轩. 原发性干燥综合征93例临床表现[J]. 中国微循环,2009,13(4):316.
|
[12] |
Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man[J]. Journal of Dental Research, 1987, 66(1):648-653.
|
[13] |
Chia E, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study[J]. Clinical Experimental Ophthalmology, 2003, 31(3):229-232.
|
[14] |
Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women[J]. Am J Ophthalmol, 2003, 136(2):318-326.
|
[15] |
杨永明,马林昆. 干眼的流行病学研究进展[J]. 国际眼科杂志,2010,10(10):1944-1946.
|
[16] |
王焕荣,赵乐. 126例干眼病因分析[J]. 中国斜视与小儿眼科杂志,2012,20(3):115-117.
|
[17] |
Karthaus M, Carratalà J, Jürgens H, et al. New Strategies in the Treatment of Infectious Complications in Haematology and Oncology:Is There a Role for Out-Patient Antibiotic Treatment of Febrile Neutropenia?[J]. Chemotherapy, 1998, 44(6):427-435.
|
[18] |
Douillard JY, Gervais R, Dabouis G, et al. Sequential two-line strategy for stage Ⅳ non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase Ⅱ study[J]. Annals of Oncology, 2005, 16(1):81-89.
|
[19] |
Maciejewski JP, Ristiano AM, Sloand EM, et al. A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome[J]. British Journal of Haematology, 2002, 117(1):119-126.
|
[20] |
Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adap-tive immune responses are associated with Sjögren's syndrome[J]. Nat Genet, 2013, 45(11):1284-1292.
|
[21] |
Li Y, Zhang K, Chen H, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23[J]. Nature Genetics, 2013, 45(11):1361-1365.
|
[22] |
Pontarini E, Lucchesi D, Bombardieri M. Current views on the pathogenesis of Sjögren's syndrome[J]. Current Opinion in Rheumatology, 2018, 30(2):215-221.
|
[23] |
Moriyama M, Hayashida JN, Toyoshima T, et al. Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome[J]. Clinical & Experimental Immunology, 2012, 169(1):17-26.
|
[24] |
Kivity S, Sneh E, Greif J, et al. The effect of food and exercise on the skin response to compound 48/80 in patients with food-associated exercise-induced urticaria-angioedema[J]. Journal of Allergy & Clinical Immunology, 1988, 81(6):1155-1158.
|
[25] |
Kivity S, Arango MT, Ehrenfeld M, et al. Infection and autoimmunity in Sjögren's syndrome: a clinical study and comprehensive review[J]. Journal of Autoimmunity, 2014, 51(2):17-22.
|
[26] |
Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN Pathways and Plasmacytoid Dendritic Cell Recruitment in Target Organs of Primary Sjögren's Syndrome[J]. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(8):2770-2775.
|
[27] |
Ciccia F, Guggino G, Rizzo A, et al. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome[J]. Annals of the Rheumatic Diseases, 2012, 71(2):295-301.
|
[28] |
张昊泽,张奉春. 深入探究干燥综合征的发病机制[J]. 中华内科杂志,2015,54(11):157-158.
|
[29] |
Lemp MA. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)[J]. Ocular Surface, 2007, 5(2):75-92.
|
[30] |
Menzies KL, Srinivasan S, Prokopich CL, et al. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls[J]. Invest Ophthalmol Vis Sci, 2015, 56(2):836-841.
|
[31] |
Amparo F, Schaumberg DA, Dana R. Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye[J]. Ophthalmology, 2015, 122(7):1498-1503.
|
[32] |
Tseng SC. A practical treatment algorithm for managing ocular surface and tear disorders[J]. Cornea, 2011, 30(Suppl. 1):8-14.
|
[33] |
Listed N. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)[J]. Ocular Surface, 2007, 5(2):108-152.
|
[34] |
Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease[J]. Deutsches Ärzteblatt International, 2015, 112(5):71-81.
|
[35] |
陆炯,梁庆丰. 角膜共聚焦显微镜检查辅助治疗干眼症的临床研究[J/CD]. 中华眼科医学杂志(电子版),2016,6(5):213-218.
|
[36] |
庄宏,徐建江. 常规眼科技术在干眼症检查方面的拓展应用[J]. 中华实验眼科杂志,2009,27(11):1050-1053.
|
[37] |
Jung JH, Ji YW, Hwang HS, et al. Proteomic analysis of human lacrimal and tear fluid in dry eye disease[J]. Sci Rep, 2017, 7(1):13363.
|
[38] |
Potvin R, Makari S, Rapuano CJ. Tear film osmolarity and dry eye disease: a review of the literature[J]. Clinical Ophthalmology, 2015, 9(default):2039-2047.
|
[39] |
Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjögren disease[J]. Ocular Surface, 2015, 13(2):118-132.
|
[40] |
Tsubota K, Fujita H, Tsuzaka K, et al. Quantitative analysis of lacrimal gland function, apoptotic figures, Fas and Fas ligand expression of lacrimal glands in dry eye patients[J]. Experimental Eye Research, 2003, 76(2):233-240.
|
[41] |
Chhadva P, Goldhardt R, Galor A. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease[J]. Ophthalmology, 2017, 124(11):20-26.
|
[42] |
Wang MT, Jaitley Z, Lord SM, et al. Comparison of Self-applied Heat Therapy for Meibomian Gland Dysfunction[J]. Optomet Vision Sci, 2015, 92(9):321-326.
|
[43] |
Nakamura T, Inatomi T, Sotozono C, et al. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease[J]. Ophthalmology, 2006, 113(10):1765-1772.
|
[44] |
姜淑华,胡丽伟,孙凤艳,等.中医辨证论治治疗干燥综合征的临床研究[J].世界最新医学信息文摘,2017,17(50):91-92.
|
[45] |
李影,高卫萍. 干眼症的中医药治疗近况[J]. 山东中医杂志,2010,29(2):139-140.
|
[46] |
Akpek EK, Lindsley KB, Adyanthaya RS, et al. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review[J]. Ophthalmology, 2011, 118(7):1242-1252.
|
[47] |
Chen H, Zhou S, Su D, et al. High-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia[J]. Clinical Rheumatology, 2013, 32(12):1783-1790.
|
[48] |
Yacoub YI, Rostom S, Laatiris A, et al. Primary Sjögren's syndrome in Moroccan patients: characteristics, fatigue and quality of life[J]. Rheumatology International, 2012, 32(9):2637-2643.
|
[49] |
文中华,李淑琳,张玉明,等. 原发性干燥综合征干眼的中西医结合治疗临床研究[J]. 眼科新进展,2015,35(12):1166-1169.
|
[50] |
Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjogren's syndrome: results from a cohort study[J]. Rheumatology, 2012, 51(2):262.
|
[51] |
Strömbeck B, Ekdahl C, Manthorpe R, et al. Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36[J]. Acta Rheumatologica Scandinavica, 2000, 29(1):20-28.
|
[52] |
Strand V, Scott DL, Emery P, et al. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis[J]. Journal of Rheumatology, 2005, 32(4):590-601.
|